NEUP
NASDAQ · Biotechnology
Neuphoria Therapeutics Inc
$4.01
+0.02 (+0.38%)
Open$3.96
Previous Close$4.00
Day High$4.10
Day Low$3.96
52W High$15.06
52W Low$9.72
Volume—
Avg Volume748.1K
Market Cap21.56M
P/E Ratio57.28
EPS$0.20
SectorBiotechnology
Analyst Ratings
Strong Buy
9 analysts
Price Target
+268.8% upside
Current
$4.01
$4.01
Target
$14.79
$14.79
$9.77
$14.79 avg
$16.23
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 5.17M | 4.87M | 5.69M |
| Net Income | -354,866 | -256,361 | -296,488 |
| Profit Margin | -6.9% | -5.3% | -5.2% |
| EBITDA | -507,265 | -425,609 | -470,962 |
| Free Cash Flow | -183,163 | -132,058 | -138,324 |
| Rev Growth | -7.1% | +6.1% | +23.1% |
| Debt/Equity | 0.39 | 0.29 | 0.38 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $223.43 | +2.01% | 165.4 | 394.89B |
| AMGN | Amgen Inc | $384.32 | +4.49% | 26.8 | 206.95B |
| GILD | Gilead Sciences Inc | $152.50 | +2.10% | 23.3 | 189.20B |
| VRTX | Vertex Pharmaceuticals Inc | $477.92 | +4.17% | 33.7 | 123.82B |
| REGN | Regeneron Pharmaceuticals | $785.51 | +2.46% | 18.4 | 83.03B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.16 | -0.93% | 995.2 | 43.35B |